Fabian Moreau

Cornerback

Age: 30
Free Agency: 2024 (UFA)
Accrued Seasons: 7
  • 2024 Salary Cap Charge: $0 (0.00% of cap)
  • 2024 Cash Payout: $0 (0.00% of spending)
  • 2024 Cash to Cap Ratio: 0
  • Contract Value: $1,100,000 ($1,100,000 APY)
  • Fully Guaranteed Money: $0
  • Contract Ranking: 120/269 at CB

Current Contract

(SFA, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryCap
Number
Cap %
Dead Money & Cap Savings
202329$1,100,000$1,100,0000.5%
Total$1,100,000$1,100,000

Contract Notes

Fabian Moreau signed with the Houston Texans on May 31, 2022. Contract base value is $2 million with $1 million guaranteed including a $350,000 signing bonus. Moreau can earn up to $250,000 (paid $14,706 per game active) in roster bonuses, and has an additional $500,000 available through playtime incentives.

Cash Flows

- fully earned money
- unearned or partially earned money
$1.1M
2023
Cash Due$1,100,000
Running Cash$1,100,000
Career Earnings: $9,270,292
Career APY: $1,324,327
Potential Earnings: $7,785,392
Total Guarantees: $3,162,892
Largest Cash Payment: $2,133,000 (2020)
Largest Cap Number: $2,339,348 (2020)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
RedskinsDraftedExpired20174$3,339,392$834,848$825,392$4,695,392140.6%$1,173,848
FalconsUFAExpired20211$1,127,500$1,127,500$987,500$1,127,500100.0%$1,127,500
TexansSFATerminated20221$2,000,000$2,000,000$1,000,000$00.0%$0
GiantsPracticeRenegotiated20221$433,400$433,400$0$00.0%$0
GiantsPracticeElevated20221$433,400$433,400$0$00.0%$0
GiantsPracticeElevated20221$358,200$358,200$0$00.0%$0
GiantsSFAExpired20221$1,035,000$1,035,000$0$862,50083.3%$862,500
BroncosSFATerminated20231$1,300,000$1,300,000$350,000$00.0%$0
BroncosSFAActive20231$1,100,000$1,100,000$0$1,100,000100.0%$1,100,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Commanders4$4,695,392$1,173,848$4,695,3920.0%$00.0%
Falcons1$1,127,500$1,127,500$987,5000.0%$00.0%
Texans0$1,000,000$0$00.0%$1,000,0000.0%
Giants1$997,400$997,400$862,5000.0%$134,9000.0%
Broncos1$1,450,000$1,450,000$1,100,0000.0%$350,0000.0%

Season History

YearTeamBase SalaryProrated BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2017Redskins$465,000$206,348$0$671,3480.4%$1,290,392
2018Redskins$588,000$206,348$0$794,3480.4%$588,000
2019Redskins$684,000$206,348$0$890,3480.5%$684,000
2020Washington$2,133,000$206,348$0$2,339,3481.1%$2,133,000
2021Falcons$990,000$137,500$850,000$987,5000.5%$1,127,500
2022Giants$1,035,000$0$0$862,5000.4%$862,500
2023Broncos$1,100,000$0$0$1,100,0000.5%$1,100,000
Total$6,995,000$962,892$850,000$7,645,392$7,785,392
Dead Money History
TeamYearCap ChargeCash Paid
Texans2022$1,000,000$1,000,000
Giants2022$134,900$134,900
Broncos2023$350,000$350,000
Total$1,484,900$1,484,900

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
201716005.4%73.3%7700001000000
2018160081.2%10.0%3721000051163000
2019124058.7%3.7%3311000053160000
2020160014.9%41.1%5200003200000
2021161088.6%4.2%4417003011000100
2022140166.2%14.4%4716000010000000
2023160165.8%4.8%331300107100000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$3,196,000$1,100,000
Injury Adjusted$3,196,000$1,100,000
test
OTC Valuation $3.1M $6.3M $9.4M $12.5M $15.7M APY $3.5M $7M $10.5M $14M $17.5M $4,253,000 $3,775,717

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.